analyst revisionsHello every one,
First of all, I would thank for high quality of bullboard comments. It's a pleasure to read all of us.
With no surprise, analysts proposes to tender:
* Prism Medical Ltd : LB Securities raises target price to C$12.50 from C$12
* Prism Medical Ltd : LB Securities revises rating to tender from buy
* Prism Medical Ltd : PI Financial cuts to tender from buy
* Prism Medical Ltd : PI Financial cuts price target to C$12.50 from C$13
For my unregistered accounts, I toying with the idea of voting against. The long term perspectives are good. If enough shareholders vote against, and Handicare take control, this company can continue to pay dividends... A fund need cash to generate revenues. But in this case, Prism will be private, unsaleable and for long term investment. Also, no assurance of future dividends.